Medical News

RSS

Birner Dental Management Services' 2009 net income up 7.5%

Birner Dental Management Services, Inc., operators of PERFECT TEETH® dental practices, announced results for the year and quarter ended December 31, 2009. For the year ended December 31, 2009, revenue increased $557,000, or 0.9%, to $59.6 million. The Company's earnings before interest, taxes, depreciation, amortization and non-cash expense associated with stock-based compensation ("Adjusted EBITDA") increased $101,000, or 1.5%, to $6.9 million.

31 Mar 2010

Accellent's net sales for fourth-quarter of 2009 decrease by 12.1%

Accellent Inc., a wholly owned subsidiary of Accellent Holdings Corp., today announced results for its fiscal fourth quarter and full year ended December 31, 2009.

31 Mar 2010

Changes in daily behavior can influence remembering to take daily medication

For many people, remembering to take a daily medication can be the difference between life and death. Yet, people forget all the time. Now a landmark study from North Carolina State University has found that changes in daily behavior have a significant effect on whether we remember to take our medication - and that these changes influence older and younger adults differently. That's good news, because it means there's something we can do about it.

31 Mar 2010

High-fructose corn syrup makes rats fat: Princeton University study questioned

"HFCS makes rats fat? I can hardly believe that Princeton sent out a press release yesterday announcing the results of this rat study. The press release says: "Rats with access to high-fructose corn syrup gained significantly more weight than those with access to table sugar, even when their overall caloric intake was the same."

31 Mar 2010

Funds raised at CASMA's spring conference to benefit The Montréal Children's Hospital

Mondial Assistance and the Computerized Airline Sales and Marketing Association announced today that a fundraiser held during a reception at CASMA's spring conference in Montréal raised enough money to purchase a saturation/end tidal carbon dioxide monitor for the Department of Anesthesia at The Montréal Children's Hospital.

31 Mar 2010

CAMH embarks on next phase of landmark redevelopment project

The Centre for Addiction and Mental Health is making history. On April 6, CAMH is breaking ground on the next phase of its landmark redevelopment project, transforming the site of what was originally the 1850 Provincial Lunatic Asylum into a modern, welcoming 'urban village' in the heart of Queen Street West. Nothing quite like this has ever been done before.

31 Mar 2010

Company affiliation is the greatest driver of farm-to-farm disease transmission risk: Study

A new study by researchers at the Johns Hopkins Bloomberg School of Public Health examines the potential influence that the business connections between broiler chicken growers may have on the transmission of avian influenza, H5N1. According to the study, the risk of between-farm transmission is significantly greater among farms within the same company group than it is between farms with different company affiliation.

31 Mar 2010

Omega Healthcare Investors agrees to sell common stock under equity distribution agreement with BofA Merrill Lynch

Omega Healthcare Investors, Inc. today announced that it has agreed to sell shares of its common stock having an aggregate offering price of $33.3 million pursuant to a terms agreement entered into under the equity distribution agreement, dated June 12, 2009, between the Company and BofA Merrill Lynch in connection with the company's previously reported $100 million Equity Shelf Program.

31 Mar 2010

BBSRC, NSF to hold intensive week long facilitated workshop to enhance photosynthesis

Leading bioscience funding bodies in the UK and USA announce plans to promote scientific proposals in the potentially transformational area of enhanced photosynthesis.

31 Mar 2010

Social networks can spread misunderstandings about proper use of antibiotics

Misunderstandings about proper use of antibiotics have the potential to spread widely through social networks such as Twitter, according to a report in the April issue of AJIC: American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology, Inc. (APIC).

31 Mar 2010

MSCHIE launches Phase 2 of HIE deployment

The Mississippi Coastal Health Information Exchange (MSCHIE) has launched Phase 2 of its HIE deployment - which will expand its services to four additional health systems, launch a community outreach training program, and integrate with additional EHR vendors throughout the community - marking a major milestone in its efforts to improve patient care coordination and clinical outcomes in the Mississippi counties hit hardest by Hurricane Katrina.

31 Mar 2010

SANUWAVE Health reports net loss of $2.7M for three months ended December 31, 2009

SANUWAVE Health, Inc., an emerging medical technology company focused on regenerative medicine, reports its financial results for the fourth quarter and full year ended December 31, 2009, and on its progress for the year.

31 Mar 2010

DSMB for DIGNITY trial recommends Celsion continue enrollment

Celsion Corporation announced today that after reviewing safety data from the 40mg/m2 cohort, the DIGNITY Study Drug Safety Monitoring Board (DSMB) has recommended that Celsion continue to enroll patients in the trial and that new patients be treated at a ThermoDox® dose of 50mg/m2.

31 Mar 2010

Hospital outpatient ER visits by Medicaid recipients increased more than 6%

SDI, a leading healthcare market insight and analytics firm, today reported that the number of Medicaid-subsidized inpatient hospital stays originating in the emergency room increased more than 6% in 2009 compared to 2008. The growth rate of all inpatient hospital stays that began in the hospital outpatient ER was less at just over 1%.

31 Mar 2010

Japanese Patent Office grants Alnylam Pharmaceuticals' claims in second patent application for Tuschl II

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the Japanese Patent Office has granted claims in a second patent application (JP Application Number 2006-317758) for the Tuschl II patent series, entitled "RNA Interference Mediating Small RNA Molecules." In May 2008, the Japanese Patent Office granted a related set of claims in the Tuschl II patent series (JP 4 095 895).

31 Mar 2010

Fully integrated medical curriculum proves beneficial for minority students

Of all the licensing exams along the way to becoming an M.D., the Step 1 is notorious for having the worst national passage rate. By adopting a fully integrated medical curriculum in lieu of the traditional academic model, the University of Texas Medical Branch has seen a dramatic drop over the course of a decade in the failure rate, with underrepresented minority students benefiting the most, according to new research that will be presented April 30, 2010 at the annual meeting of the American Educational Research Association.

31 Mar 2010

Haiti's recovery: CARE calls for substantial, sustained commitment from international community

At this week's International Donors' Conference Towards a New Future for Haiti (March 31, 2010), CARE will urge the international community to ensure all Haitians have a chance to rebuild their country anew. Women and girls, in particular, will be at the heart of CARE's policy recommendations to address Haiti's recovery, reconstruction and long-term development needs as donor countries, international organizations and other partners gather to pledge resources and commit to long-term efforts in Haiti following the devastating January earthquake.

31 Mar 2010

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

31 Mar 2010

IVAX Diagnostics reports net revenue of $4.5M for quarter ended December 31, 2009

IVAX Diagnostics, Inc., a fully integrated in vitro diagnostics company, reports its financial results for the fourth quarter and full year ended December 31, 2009.

31 Mar 2010

DATATRAK International reports 31% decrease in revenue for fourth-quarter 2009

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced its operating results for the fourth quarter and full year of 2009.

31 Mar 2010

Medical News

Birner Dental Management Services' 2009 net income up 7.5%

Accellent's net sales for fourth-quarter of 2009 decrease by 12.1%

Changes in daily behavior can influence remembering to take daily medication

High-fructose corn syrup makes rats fat: Princeton University study questioned

Funds raised at CASMA's spring conference to benefit The Montréal Children's Hospital

CAMH embarks on next phase of landmark redevelopment project

Company affiliation is the greatest driver of farm-to-farm disease transmission risk: Study

Omega Healthcare Investors agrees to sell common stock under equity distribution agreement with BofA Merrill Lynch

BBSRC, NSF to hold intensive week long facilitated workshop to enhance photosynthesis

Social networks can spread misunderstandings about proper use of antibiotics

MSCHIE launches Phase 2 of HIE deployment

SANUWAVE Health reports net loss of $2.7M for three months ended December 31, 2009

DSMB for DIGNITY trial recommends Celsion continue enrollment

Hospital outpatient ER visits by Medicaid recipients increased more than 6%

Japanese Patent Office grants Alnylam Pharmaceuticals' claims in second patent application for Tuschl II

Fully integrated medical curriculum proves beneficial for minority students

Haiti's recovery: CARE calls for substantial, sustained commitment from international community

Rosetta Genomics reports revenues of $150,000 for full-year 2009

IVAX Diagnostics reports net revenue of $4.5M for quarter ended December 31, 2009

DATATRAK International reports 31% decrease in revenue for fourth-quarter 2009

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News